Reporter : Li Yun / Editor: Deming / https://www.ntdtv.com/gb/2020/10/16/a102964296.html / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
As covi continues to spread, scientists are intensively developing vaccines around the world, and several vaccines have entered the third phase of clinical trials. But so far, no vaccine has passed the final scientific verification.
However, in China, although the formal R&D has not yet ended, hundreds of thousands of people have been vaccinated with one of the three vaccine candidates.
According to a report by Sina Finance and Economics of the Communist Party of China on 11 September, the person in charge of Sinopharm China Biotechnology recently claimed that the two inactivated vaccines developed by Sinopharm China Biotechnology Co., Ltd. have urgently used the Chinese virus inactivated vaccine and overseas phase III clinical research. Hundreds of thousands of people have been vaccinated, and there has been no obvious adverse reaction or infection.
The person in charge also said that tens of thousands of people who have gone to overseas high-risk countries and regions after the vaccine has been infected so far.
Experts from various countries are shocked by the CCP’s approach: vaccines that have not been clinically verified may cause serious side effects, and vaccinators may mistakenly believe that they have immunity, thereby relaxing their vigilance and causing greater spread.
350,000 people have been vaccinated with the vaccine developed by the CCP
In September, the Associated Press quoted a senior official of China National Pharmaceutical Group as saying that Sinopharm is developing two vaccines. This company alone has vaccinated 350,000 people outside the scope of official vaccine clinical trials. The company also provided 200,000 doses of vaccines to Wuhan to vaccinate medical workers in the city.
Another company, CanSino Bio, vaccinated more than 90% of its employees and their families, involving about 3,000 people. Yin Weidong, general manager of Kexing Biotech, said the company has also provided tens of thousands of vaccines to the Beijing Municipal Government. He himself was vaccinated against covi a few months ago.
The Wall Street Journal quoted two prospective Chinese students as saying that they were notified after registering on the website of Sinopharm Group. One of the vaccinated Chen students said that she signed a consent form before the vaccination. The consent form informed the vaccine is still in clinical trials and may cause side effects such as headaches and arm pain.
Student Chen also submitted the admission notice, visa copy and flight information from a British university.
The CCP's information on vaccine development is not transparent
China's information on vaccine research and development has never been transparent enough, and it does not follow general international norms. There is also widespread concern that these vaccines may have unpredictable risks.
Based on inquiry on the official website of China's National Medical Products Administration, information about how many manufacturers of the Chinese Communist Party virus vaccine have participated in the development, which stage it has reached, how many volunteers have participated in the experiment, and whether anyone has had adverse reactions, cannot be found.
However, at present, the official website of Sinopharm Group cannot find the information that can be registered for vaccination, and the registration website circulating on WeChat, After clicking the link, it displays "system maintenance, intent investigation completed."
Even more paradoxically, the Chinese Communist Party's official media "Health Times" again quoted an unnamed person from Sinopharm Group on October 14 as saying that "relevant information about the vaccination is untrue."
Lawrence Gostin, professor of global health law at Georgetown University in the United States, told Radio Free Asia via email, “Failure to comply with all the ethical and normative standards that should be followed during the vaccine clinical trial phase, which may cause catastrophic harm to the population. Even minor safety risks in vaccine experiments may be amplified."
Goldstein said that if the report that Sinopharm gave priority to foreign students to fight against is true, "it will be extremely difficult to observe possible vaccine reactions among overseas students. It will not be possible to quickly detect and correct possible problems, and it will be possible for students to develop serious adverse effects."
Li Dunhou, professor emeritus of the Harvard University School of Public Health, said that generally speaking, in the vaccine development stage, first-line medical staff are usually involved in voluntary injection. Personnel are highly sensitive to possible adverse situations.
Li Dunhou said that under the circumstances that China's information is not open and transparent, it is incomprehensible why Sinopharm targeted foreign students. This may not be a clinical trial in name, but it is actually a clinical trial. This can be said to be a kind of observational study. A more civilized society with the rule of law would not do this.
The U.S. and China practices are very different
Free Asia reported that in response to a pandemic emergency, the United States and China have very different approaches.
In accordance with the guidelines of the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), any vaccine development must go through two stages, from animal experiments to the second phase of human clinical trials. In the clinical trial phase, there are also three phases of experimental requirements with different numbers of people. The first phase requires 20 to 100 people, the second phase requires hundreds of people, and the third phase requires more than 100,000 voluntary participants.
In this clinical trial of the CCP virus vaccine, the National Institute of Allergy and Infectious Diseases (NIAID) of the United States organized a unified online registration for volunteers to accept clinical trials for five pharmaceutical companies. Volunteers must be 18 years old, and the Internet also clearly informed that the vaccine in the clinical trial stage "does not guarantee zero risk."
At the same time, it shows that volunteers will need more than 10 visits in one to two years to help researchers in follow-up research and investigation.
According to reports, there are currently three CCP virus vaccines in the third phase of clinical trials in the United States due to adverse reactions caused by vaccinators. The pharmaceutical companies have suspended the trials and waited for further instructions from the FDA to resume.
No comments:
Post a Comment